Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer (CARIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00868634
Recruitment Status : Completed
First Posted : March 25, 2009
Last Update Posted : August 31, 2016
Arbeitsgemeinschaft fur Internistische Onkologie
Arbeitskreis Klinische Studien
Roche Pharma AG
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2014
  Study Completion Date : October 2015